PubRank

William A Banks

Author PubWeight™ 133.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006 4.25
2 Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003 3.57
3 Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002 2.67
4 Brain-immune communication pathways. Brain Behav Immun 2007 2.50
5 Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide. Brain Behav Immun 2005 2.18
6 Strategies to advance translational research into brain barriers. Lancet Neurol 2008 2.16
7 Effects of leptin on memory processing. Peptides 2005 1.97
8 Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci U S A 2004 1.97
9 Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 2008 1.94
10 Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 2003 1.82
11 The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 2003 1.67
12 Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 2003 1.60
13 The effects of animal-assisted therapy on loneliness in an elderly population in long-term care facilities. J Gerontol A Biol Sci Med Sci 2002 1.51
14 Peroxisome proliferator-activated receptor-gamma-mediated positive energy balance in the rat is associated with reduced sympathetic drive to adipose tissues and thyroid status. Endocrinology 2008 1.47
15 Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab 2013 1.45
16 HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res 2005 1.39
17 Characterizaton of short isoforms of the leptin receptor in rat cerebral microvessels and of brain uptake of leptin in mouse models of obesity. Endocrinology 2002 1.36
18 Permeability of the blood-brain barrier to a novel satiety molecule nesfatin-1. Peptides 2007 1.35
19 Pharmacological profiles of peptide drug candidates for the treatment of Alzheimer's disease. J Biol Chem 2003 1.34
20 Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease. Brain Behav Immun 2009 1.32
21 Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes 2006 1.27
22 Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery. Bioconjug Chem 2005 1.26
23 Animal-assisted therapy and loneliness in nursing homes: use of robotic versus living dogs. J Am Med Dir Assoc 2008 1.23
24 Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor. Proc Natl Acad Sci U S A 2007 1.18
25 Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 2009 1.17
26 Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 2009 1.17
27 Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation 2011 1.16
28 Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J Neurosci Res 2010 1.15
29 Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav Immun 2011 1.15
30 Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse. Mol Ther 2008 1.14
31 A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp Neurol 2006 1.12
32 Topiramate treatment protects blood-brain barrier pericytes from hyperglycemia-induced oxidative damage in diabetic mice. Endocrinology 2011 1.11
33 Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J 2002 1.11
34 Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier. J Neuroinflammation 2012 1.09
35 Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther 2003 1.08
36 Effects of orexin-A on memory processing. Peptides 2002 1.07
37 N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res 2009 1.06
38 HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic Biol Med 2010 1.06
39 Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology 2008 1.05
40 Pegylated leptin antagonist is a potent orexigenic agent: preparation and mechanism of activity. Endocrinology 2009 1.04
41 A physiological role for amyloid-beta protein:enhancement of learning and memory. J Alzheimers Dis 2010 1.04
42 Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 2004 1.04
43 Transport across the blood-brain barrier of pluronic leptin. J Pharmacol Exp Ther 2010 1.01
44 Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models. J Cereb Blood Flow Metab 2008 1.01
45 Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells. Free Radic Biol Med 2010 1.01
46 Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res 2005 1.00
47 Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier. Exp Neurol 2005 1.00
48 Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery. Bioconjug Chem 2008 0.99
49 Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier. Neuroimmunomodulation 2012 0.99
50 Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway. Exp Neurol 2008 0.98
51 Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by luminal microvessel IL-6 and GM-CSF. J Neuroinflammation 2011 0.98
52 Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways. J Neuroimmune Pharmacol 2008 0.97
53 Ghrelin-induced feeding is dependent on nitric oxide. Peptides 2003 0.97
54 Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci 2007 0.97
55 Brain distribution and behavioral effects of progesterone and pregnenolone after intranasal or intravenous administration. Eur J Pharmacol 2010 0.96
56 Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res Mol Brain Res 2005 0.96
57 Lipids and cognition. J Alzheimers Dis 2010 0.96
58 Leptin and adiponectin levels in middle-aged postmenopausal women: associations with lifestyle habits, hormones, and inflammatory markers--a cross-sectional study. Metabolism 2006 0.95
59 Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radic Biol Med 2010 0.95
60 Higher C-reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci 2009 0.95
61 Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain. J Alzheimers Dis 2012 0.94
62 Pharmacological inhibition of mitochondrial carbonic anhydrases protects mouse cerebral pericytes from high glucose-induced oxidative stress and apoptosis. J Pharmacol Exp Ther 2012 0.94
63 Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab 2011 0.93
64 Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins. J Pharmacol Exp Ther 2008 0.92
65 Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors. Proc Natl Acad Sci U S A 2005 0.92
66 Alzheimer's disease through the eye of a mouse. Acceptance lecture for the 2001 Gayle A. Olson and Richard D. Olson prize. Peptides 2002 0.92
67 Effects of lipopolysaccharide on leptin transport across the blood-brain barrier. Brain Res 2004 0.92
68 Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med 2003 0.92
69 Extra virgin olive oil improves learning and memory in SAMP8 mice. J Alzheimers Dis 2012 0.92
70 Lower serum DHEAS levels are associated with a higher degree of physical disability and depressive symptoms in middle-aged to older African American women. Maturitas 2007 0.91
71 Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 2005 0.91
72 Ovine proinflammatory cytokines cross the murine blood-brain barrier by a common saturable transport mechanism. Neuroimmunomodulation 2010 0.91
73 Passage of vasoactive intestinal peptide across the blood-brain barrier. Peptides 2003 0.90
74 Dietary components in the development of leptin resistance. Adv Nutr 2013 0.89
75 Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine. Brain Behav Immun 2012 0.89
76 Human immunodeficiency virus-1 uses the mannose-6-phosphate receptor to cross the blood-brain barrier. PLoS One 2012 0.88
77 High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: Implications for cerebral microvascular disease in diabetes. Biochem Biophys Res Commun 2013 0.88
78 Potentiation of lead-induced cell death in PC12 cells by glutamate: protection by N-acetylcysteine amide (NACA), a novel thiol antioxidant. Toxicol Appl Pharmacol 2006 0.88
79 Chronic ethanol consumption impairs learning and memory after cessation of ethanol. Alcohol Clin Exp Res 2005 0.88
80 DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice. Life Sci 2004 0.88
81 HIV-1-induced production of endothelin-1 in an in vitro model of the human blood-brain barrier. Neuroreport 2002 0.88
82 Rapid transport of CCL11 across the blood-brain barrier: regional variation and importance of blood cells. J Pharmacol Exp Ther 2014 0.87
83 Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. Mol Pharm 2012 0.87
84 Predictors of serum testosterone and DHEAS in African-American men. Int J Androl 2008 0.86
85 Mediation of chronic pain: not by neurons alone. Pain 2006 0.86
86 A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administration. J Pharmacol Exp Ther 2010 0.86
87 Brain pericytes increase the lipopolysaccharide-enhanced transcytosis of HIV-1 free virus across the in vitro blood-brain barrier: evidence for cytokine-mediated pericyte-endothelial cell crosstalk. Fluids Barriers CNS 2013 0.85
88 SAMP8 mice have altered hippocampal gene expression in long term potentiation, phosphatidylinositol signaling, and endocytosis pathways. Neurobiol Aging 2013 0.85
89 Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol A Biol Sci Med Sci 2003 0.84
90 Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid beta protein, and age. Peptides 2002 0.84
91 Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 2008 0.84
92 Blind mice are not impaired in T-maze footshock avoidance acquisition and retention. Physiol Behav 2002 0.83
93 Transport of antisense across the blood-brain barrier. Methods Mol Med 2005 0.83
94 Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation. Am J Physiol Regul Integr Comp Physiol 2009 0.82
95 Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. J Neuroinflammation 2012 0.82
96 Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer. Exp Neurol 2005 0.82
97 Opiate modulation of IL-1alpha, IL-2, and TNF-alpha transport across the blood-brain barrier. Brain Behav Immun 2008 0.82
98 Orexin-A-induced feeding is dependent on nitric oxide. Peptides 2005 0.82
99 Intranasal administration of PACAP: uptake by brain and regional brain targeting with cyclodextrins. Peptides 2012 0.81
100 Antibody to beta-amyloid protein increases acetylcholine in the hippocampus of 12 month SAMP8 male mice. Life Sci 2003 0.81
101 Nitric oxide activity and isoenzyme expression in the senescence-accelerated mouse p8 model of Alzheimer's disease: effects of anti-amyloid antibody and antisense treatments. J Gerontol A Biol Sci Med Sci 2009 0.81
102 Chronic peripheral administration of somatostatin receptor subtype-4 agonist NNC 26-9100 enhances learning and memory in SAMP8 mice. Eur J Pharmacol 2010 0.81
103 Mechanisms of HIV type 1-induced cognitive impairment: evidence for hippocampal cholinergic involvement with overstimulation of the VIPergic system by the viral coat protein core. AIDS Res Hum Retroviruses 2002 0.81
104 Permeability of the blood-brain barrier to a rhenacarborane. J Pharmacol Exp Ther 2009 0.80
105 Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. J Exp Biol 2009 0.80
106 Hyperhomocysteinemic mice show cognitive impairment without features of Alzheimer's disease phenotype. J Alzheimers Dis 2013 0.80
107 Copper complexing decreases the ability of amyloid beta peptide to cross the BBB and enter brain parenchyma. Peptides 2007 0.79
108 Soluble interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits. PLoS One 2012 0.79
109 Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake. FASEB J 2011 0.79
110 Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases. AAPS J 2015 0.79
111 Protective effects of an anti-melanocortin-4 receptor scFv derivative in lipopolysaccharide-induced cachexia in rats. J Cachexia Sarcopenia Muscle 2012 0.79
112 The blood-brain barrier as a cause of disease. Curr Pharm Des 2008 0.78
113 Nitric oxide is a central component in neuropeptide regulation of appetite. Peptides 2011 0.78
114 Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier. Immunotherapy 2010 0.78
115 Antisense therapeutics and the treatment of CNS disease. Front Biosci 2004 0.78
116 Effects of chronic ethanol administration on brain interstitial fluid levels of Methionine-enkephalin as measured by microdialysis in vivo. Peptides 2006 0.77
117 Disruption of the integrity and function of brain microvascular endothelial cells in culture by exposure to diesel engine exhaust particles. Toxicol Lett 2013 0.77
118 Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation. Am J Physiol Regul Integr Comp Physiol 2010 0.77
119 Effect of alpha-lipoic acid on memory, oxidation, and lifespan in SAMP8 mice. J Alzheimers Dis 2012 0.77
120 Somatostatin receptor subtype-4 agonist NNC 26-9100 decreases extracellular and intracellular Aβ₁₋₄₂ trimers. Eur J Pharmacol 2012 0.77
121 The dam breaks: disruption of the blood-brain barrier in diabetes mellitus. Am J Physiol Heart Circ Physiol 2006 0.75
122 Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ(42) oligomers via a metalloproteinase-dependent mechanism. Brain Res 2013 0.75
123 Decreased blood-brain barrier expression of P-glycoprotein in Alzheimer's disease: impact on pathogenesis and brain access of therapeutic agents. Ther Deliv 2011 0.75
124 In vitro methods in the study of viral and prion permeability across the blood-brain barrier. Cell Mol Neurobiol 2005 0.75
125 Development of peptide receptor binding assays: methods to avoid false negatives. Regul Pept 2009 0.75
126 Toward better times: the period of improving animal models in the quest for the treatment of disease. Crit Care Med 2006 0.75
127 Foreword. Curr Pharm Des 2014 0.75
128 Foreword. Curr Pharm Des 2015 0.75
129 Quantifying altitude of human habitation in studies of human health using geographical name server data. Geospat Health 2016 0.75